GoingToMeet

The Current Trends in Genitourinary Malignancies regional symposium is designed to provide updates on the clinical management of kidney, bladder, and prostate cancers. Participants will be updated on current concepts in surgical, chemotherapeutic, and multimodality approaches to the treatment of bladder cancer. Relevant data on the molecular elements of prostate cancer and the clinical management of patients with prostate-specific antigen relapse and high-risk localized disease will be covered. Participants will review available clinical data on conventional chemotherapy, hormonal therapy, novel targeted and combination therapy, and immunotherapy for the treatment of advanced and castration-resistant prostate cancer. The molecular biology of the pathogenesis of renal cell carcinoma and trial data on novel and second-generation antiangiogenic agents will be presented. Experts will apprise attendees of relevant trial data in order to aid in choosing individualized treatment for patients with advanced kidney cancer across multiple lines of therapy. This interactive symposium will include didactic sessions, case-based learning, and panel discussions with leading faculty who will offer their opinions regarding the clinical challenges facing practicing physicians.

The purpose of this activity is to inform participants of the latest advances in the treatment of genitourinary malignancies, promote the integration of those advances into the practice setting, and describe future directions in research and clinical trials.